HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Apurvasena Parikh Selected Research

Duration of Therapy

2/2022First-in-human phase 1 study of budigalimab, an anti-PD-1 inhibitor, in patients with non-small cell lung cancer and head and neck squamous cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Apurvasena Parikh Research Topics

Disease

3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2023 - 11/2021
3Neoplasms (Cancer)
01/2021 - 11/2018
1Squamous Cell Carcinoma of Head and Neck
02/2022
1Disease Progression
02/2022
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2021
1Hypoalbuminemia
01/2021
1Nausea
01/2021
1Menorrhagia
12/2020
1Pain (Aches)
12/2020
1Leiomyoma (Uterine Fibroids)
12/2020
1Endometriosis
12/2020
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2018
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2018
1Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2018
1Hepatitis C
10/2016
1Infections
10/2016
1Sickle Cell Anemia (Hemoglobin S Disease)
11/2011

Drug/Important Bio-Agent (IBA)

4telisotuzumab vedotinIBA
10/2023 - 11/2018
3budigalimabIBA
02/2022 - 01/2021
3Immunoconjugates (Immunoconjugate)IBA
11/2021 - 11/2018
1ErbB Receptors (EGF Receptor)IBA
10/2023
1Proteins (Proteins, Gene)FDA Link
10/2023
1Erlotinib Hydrochloride (CP 358,774)FDA Link
10/2023
1LigandsIBA
02/2022
1Aligeron (AS 2)IBA
01/2021
1Programmed Cell Death 1 ReceptorIBA
01/2021
1rovalpituzumab tesirineIBA
01/2021
1elagolixIBA
12/2020
1LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA
12/2020
1Estradiol (Delestrogen)FDA LinkGeneric
12/2020
1Norethindrone Acetate (Norlutate)FDA LinkGeneric
12/2020
1venetoclaxIBA
01/2018
1Antiviral Agents (Antivirals)IBA
10/2016
1Tacrolimus (Prograf)FDA LinkGeneric
10/2016
1Cyclosporine (Ciclosporin)FDA LinkGeneric
10/2016
1vanillinIBA
11/2011

Therapy/Procedure

1Duration of Therapy
02/2022
1Liver Transplantation
10/2016